Source Natural Foods and Herbal Supplements Limited (SOURCENTRL.BO)
INR 206.05
(-5.89%)
INR 206.05
(-5.89%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 21.78 Million | 25.12 Million | -7.03 Million | 44.63 Million | -3.63 Million | 26.4 Million |
| Net Income | 17.36 Million | 27.35 Million | 36.81 Million | 40.46 Million | 18.47 Million | 10.55 Million |
| Depreciation & Amortization | 10.43 Million | 3.53 Million | 4.15 Million | 3.68 Million | 3.37 Million | 3.37 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6.01 Million | -1.85 Million | -20.67 Million | 5.87 Million | -25.04 Million | 11.14 Million |
| Other non-cash items | 26.71 Million | -3.91 Million | -27.33 Million | -5.38 Million | -438 Thousand | 1.32 Million |
| Investing Cash Flow | 6.15 Million | 557 Thousand | 677 Thousand | -20.48 Million | -7.06 Million | -3.07 Million |
| Investments in PPE | - | - | -15.42 Million | -12.54 Million | -765 Thousand | -3.33 Million |
| Acquisitions | - | 791 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 6.15 Million | -234 Thousand | 16.1 Million | -7.93 Million | -6.29 Million | 254 Thousand |
| Financing Cash Flow | 1.53 Million | -5.27 Million | -11.97 Million | 3.19 Million | 3.24 Million | -15.96 Million |
| Debt repayment | -200 Thousand | -181 Thousand | -8.91 Million | -1.84 Million | -9.52 Million | -16.08 Million |
| Dividends payments | - | - | - | - | -6.43 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.73 Million | -5.09 Million | -3.05 Million | 5.04 Million | 19.21 Million | 111 Thousand |
| Accounts receivables | -1 Million | 3.3 Million | - | 8.06 Million | -34.59 Million | 7.95 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -4.84 Million | -10.53 Million | -10.27 Million | -5.08 Million | 7.46 Million | 2.13 Million |
| Other working capital | -168 Thousand | 5.37 Million | -10.4 Million | 2.88 Million | 2.08 Million | 1.05 Million |
| Cash at beginning of period | 28.58 Million | 8.72 Million | 27.06 Million | 133 Thousand | 7.58 Million | 223 Thousand |
| Cash at end of period | 58.62 Million | 29.14 Million | 8.72 Million | 27.06 Million | 133 Thousand | 7.58 Million |
| Capital Expenditure | - | - | -15.42 Million | -12.54 Million | -765 Thousand | -3.33 Million |
| Effect of forex changes on cash | - | - | - | -419 Thousand | - | 1000.00 |
| Net cash flow / Change in cash | 30.04 Million | 20.41 Million | -18.33 Million | 26.92 Million | -7.44 Million | 7.35 Million |
| Free Cash Flow | 21.78 Million | 25.12 Million | -22.45 Million | 32.08 Million | -4.4 Million | 23.07 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 17.36 Million | 9.63 Million | 1.83 Million | 2.67 Million | 27.35 Million | 11.08 Million |
| Depreciation & Amortization | 10.43 Million | 2.59 Million | 4.26 Million | 1.01 Million | 3.53 Million | 1.04 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6.01 Million | - | - | - | -1.85 Million | - |
| Other non-cash items | 26.71 Million | -7.03 Million | -4.26 Million | -1.01 Million | -3.91 Million | -1.04 Million |
| Investing Cash Flow | 6.15 Million | - | - | - | 557 Thousand | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | 791 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 6.15 Million | - | - | - | -234 Thousand | - |
| Financing Cash Flow | 1.53 Million | - | - | - | -5.27 Million | - |
| Debt repayment | -200 Thousand | - | - | - | -181 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.73 Million | - | - | - | -5.09 Million | - |
| Accounts receivables | -1 Million | - | - | - | 3.3 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -4.84 Million | - | - | - | -10.53 Million | - |
| Other working capital | -168 Thousand | - | - | - | 5.37 Million | - |
| Cash at beginning of period | 28.58 Million | 29.56 Million | 27.73 Million | 28.58 Million | 8.72 Million | 17.49 Million |
| Cash at end of period | 58.62 Million | 34.76 Million | 29.56 Million | 2.67 Million | 29.14 Million | 28.58 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 30.04 Million | 5.19 Million | 1.83 Million | -25.9 Million | 20.41 Million | 11.08 Million |
| Free Cash Flow | 21.78 Million | 5.19 Million | 1.83 Million | 2.67 Million | 25.12 Million | 11.08 Million |
025820
SOMICONVEY
NAOV
6609
FOBIF
SOMMF